These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3589698)

  • 1. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.
    Hines JD; Mazza JJ; Oken MM; Bennett JM; Adelstein DJ; Keller A; O'Connell MJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):117-9. PubMed ID: 3839318
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
    Garewal H; Durie BG; Greenberg B
    Oncology; 1987; 44(6):333-5. PubMed ID: 3684173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
    Powell BL; Capizzi RL; Lyerly ES; Cooper MR
    J Clin Oncol; 1986 Jan; 4(1):95-7. PubMed ID: 3001234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinduction chemotherapy for acute nonlymphocytic leukemia.
    Letendre L; Kiely JM; Hoagland HC
    Mayo Clin Proc; 1984 Sep; 59(9):618-21. PubMed ID: 6381915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
    Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
    Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New combination chemotherapy of adult acute nonlymphocytic leukemia].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K; Tanaka K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2314-21. PubMed ID: 2937862
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with daunorubicin, cytosine arabinoside and prednisolone (DAP) in acute nonlymphocytic leukemia.
    Kaku K; Nakashima K; Shinohara K; Hiroshige Y; Ishida Y; Fujii S; Yaga K; Matsumoto N; Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):881-6. PubMed ID: 7331708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modified VAPA therapy in children with acute nonlymphocytic leukemia].
    Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M
    Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627
    [No Abstract]   [Full Text] [Related]  

  • 13. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
    Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH
    J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
    Forman SJ; Nademanee AP; O'Donnell MR; Fahey JL; Snyder DS; Farbstein MJ; Lazar GS; DuBois NJ; Blume KG
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):114-6. PubMed ID: 4012336
    [No Abstract]   [Full Text] [Related]  

  • 15. [High-dose treatment].
    Takaku F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
    Chan HY; Meyers FJ; Lewis JP
    Cancer Chemother Pharmacol; 1987; 20(3):265-6. PubMed ID: 3677301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia.
    Dekker AW; Punt K; Verdonck LF
    Haematol Blood Transfus; 1987; 30():333-5. PubMed ID: 3623240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.